Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cybin Inc CYBN


Primary Symbol: N.CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.


NEO:CYBN - Post by User

Comment by Gordinnoon Sep 07, 2021 10:19am
250 Views
Post# 33818503

RE:RE:RE:RE:MILESTONES

RE:RE:RE:RE:MILESTONES
realitycheck00 wrote: Read the acquisition press release as you are beyond confused.  The acquisition based part of the price as broken down into milestone payments.  i.e Adelia would recieve part of the aquisition amount in tranches based on milestones.  If you dont understand this and the fact that its a better way to acquire a company as to ensure milestones are met before payments are release then YES you are confused.  The fact that progress is being announced means the company is progressing.  Its not Cybin executives receiving payments its Adelia folks earning their milestones as part of the original agreement.

Done with explaining to a confused person common sense business fundementals.


Any company progressing usually takes the SP up.When they come out with that news the  Sp goes down.No coincidence just like there overnight PP ,what a joke that was .GL
<< Previous
Bullboard Posts
Next >>